Trial Profile
A Phase II Trial of Combination Capecitabine, Oxaliplatin and Bevacizumab in Treatment of Advanced Hepatocellular Carcinoma (HCC)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2007
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 06 Nov 2007 New trial record.